|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print November 7, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00697.2002
Submitted on August 9, 2002
Accepted on October 30, 2002
1 Department of Pharmacolgoy, Medical College of Wisconsin, Milwaukee, WI, USA
2 Department of Toxicology and Physiology, Medical College of Wisconsin, Milwaukee, WI, USA
* To whom correspondence should be addressed. E-mail: pli{at}mcw.edu.
We tested the hypothesis that ceramide induces endothelial dysfunction in small coronary arteries via NADPH oxidase-mediated superoxide and resulting peroxynitrite formation. Using dihydroethidium as a superoxide indicator, C2-ceramide was found to increase superoxide concentrations in the endothelium of small coronary arteries. This increase was inhibited by NADPH oxidase inhibitors N-vanillylnonanamide, apocynin and diphenylene iodonium. NADPH oxidase expression was confirmed in endothelial cells, as indicated by the immunoblotting of its subunits gp91phox and p47phox. C2-ceramide increased NADPH oxidase activity by 52%, which was blocked by NADPH oxidase inhibitors but not by inhibitors of NO synthase, xanthine oxidase and mitochondrial electron transport chain enzymes. By Western blot analysis, ceramide-induced NADPH oxidase activation was found to be associated with the translocation of p47phox to the membrane. In isolated and pressurized small coronary arteries, N-vanillylnonanamide, apocynin, or uric acid, a peroxynitrite scavenger, largely restored the inhibitory effects of ceramide on bradykinin- and A23187-induced vasorelaxation. Using nitrotyrosine as a marker, C2-ceramide was found to increase peroxynitrite in small coronary arteries, which could be blocked by uric acid. We conclude that NADPH oxidase-mediated superoxide production and subsequent peroxynitrite formation mediate ceramide-induced endothelial dysfunction in small coronary arteries.
This article has been cited by other articles:
![]() |
L. Wang, A. R. Sapuri-Butti, H. H. Aung, A. N. Parikh, and J. C. Rutledge Triglyceride-rich lipoprotein lipolysis increases aggregation of endothelial cell membrane microdomains and produces reactive oxygen species Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H237 - H244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jin, Y. Zhang, F. Yi, and P.-L. Li Critical Role of Lipid Raft Redox Signaling Platforms in Endostatin-Induced Coronary Endothelial Dysfunction Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 485 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Baudry, E. Laemmel, and E. Vicaut In vivo reactive oxygen species production induced by ischemia in muscle arterioles of mice: involvement of xanthine oxidase and mitochondria Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H821 - H828. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-E. Chow, Y.-C. Hshu, J.-S. Wang, and J.-K. Chen Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages J Appl Physiol, April 1, 2007; 102(4): 1520 - 1527. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhang, F. Zhang, R. Muh, F. Yi, K. Chalupsky, H. Cai, and P.-L. Li Autocrine/paracrine pattern of superoxide production through NAD(P)H oxidase in coronary arterial myocytes Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H483 - H495. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jacobi, S. Sela, H. I. Cohen, J. Chezar, and B. Kristal Priming of polymorphonuclear leukocytes: a culprit in the initiation of endothelial cell injury Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2051 - H2058. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gulbins and P. L. Li Physiological and pathophysiological aspects of ceramide Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R11 - R26. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Zhang, F. Yi, G. Zhang, E. Gulbins, and P.-L. Li Lipid Raft Clustering and Redox Signaling Platform Formation in Coronary Arterial Endothelial Cells Hypertension, January 1, 2006; 47(1): 74 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vecchione, E. Patrucco, G. Marino, L. Barberis, R. Poulet, A. Aretini, A. Maffei, M. T. Gentile, M. Storto, O. Azzolino, et al. Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3K{gamma} J. Exp. Med., April 18, 2005; 201(8): 1217 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Zhang, E. G. Teggatz, A.-P. Zou, W. B. Campbell, and P.-L. Li Endostatin uncouples NO and Ca2+ response to bradykinin through enhanced O2-{middle dot} production in the intact coronary endothelium Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H686 - H694. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Didion and F. M. Faraci Ceramide-Induced Impairment of Endothelial Function Is Prevented by CuZn Superoxide Dismutase Overexpression Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 90 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Z. Yang, A. Y. Zhang, F.-X. Yi, P.-L. Li, and A.-P. Zou Redox regulation of HIF-1alpha levels and HO-1 expression in renal medullary interstitial cells Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1207 - F1215. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |